MYOK
T. Rowe Price Associates’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,480,943
| Closed | -$747M | – | 2751 |
|
|
2020
Q3 | $747M | Buy |
5,480,943
+1,235,028
| +29% | +$168M | 0.09% | 235 |
|
|
2020
Q2 | $410M | Buy |
4,245,915
+657,401
| +18% | +$63.5M | 0.05% | 323 |
|
|
2020
Q1 | $168M | Buy |
3,588,514
+9,806
| +0.3% | +$460K | 0.03% | 453 |
|
|
2019
Q4 | $261M | Sell |
3,578,708
-58,847
| -2% | -$4.29M | 0.03% | 426 |
|
|
2019
Q3 | $190M | Buy |
3,637,555
+120,686
| +3% | +$6.29M | 0.03% | 460 |
|
|
2019
Q2 | $176M | Buy |
3,516,869
+132,654
| +4% | +$6.65M | 0.02% | 497 |
|
|
2019
Q1 | $176M | Buy |
3,384,215
+901,783
| +36% | +$46.9M | 0.03% | 500 |
|
|
2018
Q4 | $121M | Buy |
2,482,432
+14,024
| +0.6% | +$685K | 0.02% | 559 |
|
|
2018
Q3 | $161M | Buy |
2,468,408
+102,500
| +4% | +$6.68M | 0.02% | 543 |
|
|
2018
Q2 | $117M | Buy |
2,365,908
+368,147
| +18% | +$18.3M | 0.02% | 615 |
|
|
2018
Q1 | $97.5M | Buy |
1,997,761
+624,243
| +45% | +$30.5M | 0.02% | 655 |
|
|
2017
Q4 | $57.8M | Buy |
1,373,518
+555,393
| +68% | +$23.4M | 0.01% | 811 |
|
|
2017
Q3 | $35.1M | Buy |
818,125
+676,939
| +479% | +$29M | 0.01% | 986 |
|
|
2017
Q2 | $1.85M | Sell |
141,186
-94,397
| -40% | -$1.24M | ﹤0.01% | 1574 |
|
|
2017
Q1 | $3.1M | Buy |
235,583
+123,275
| +110% | +$1.62M | ﹤0.01% | 1487 |
|
|
2016
Q4 | $1.45M | Buy |
+112,308
| New | +$1.45M | ﹤0.01% | 1642 |
|